[Skip to Navigation]
Sign In

May 2022, Vol 3, No. 5

May 24, 2022
In the News

After Mandate, COVID-19 Vaccinations Increased Among Nursing Home Staff

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e222069. doi:10.1001/jamahealthforum.2022.2069
May 20, 2022
Viewpoint

An Integrated Framework for Achieving National Health Goals

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221109. doi:10.1001/jamahealthforum.2022.1109

This Viewpoint proposes a practical framework for accomplishing national health goals that health systems and clinicians can adopt and policy makers can fund.

Original Investigation

Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221096. doi:10.1001/jamahealthforum.2022.1096

This cross-sectional study examines whether new formulations of brand-name novel drugs were associated with novel drugs’ sales and/or therapeutic value as well as characterizes new formulations’ approval timing relative to the novel drug’s generic approval.

Evaluation of Prostate Cancer Screening Strategies in a Low-Resource, High-risk Population in the Bahamas

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221116. doi:10.1001/jamahealthforum.2022.1116

This decision analytical model of prostate cancer screening programs in the Bahamas evaluates the projected benefit of limited screening programs and the implied resources required for their sustainable implementation.

Research Letter

Trends in Medical Debt During the COVID-19 Pandemic

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221031. doi:10.1001/jamahealthforum.2022.1031

This cross-sectional study evaluates the association between the COVID-19 pandemic and reported new medical debt from 2018 to 2021 across the US.

Correction

Error in Funding/Support

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221390. doi:10.1001/jamahealthforum.2022.1390
May 19, 2022
JAMA Forum

The Uncertain Future of Policies to Promote Access and Affordability Put in Place During the COVID-19 Pandemic

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221980. doi:10.1001/jamahealthforum.2022.1980
May 17, 2022
In the News

Firearm-Related Deaths Surged During COVID-19 Pandemic’s First Year

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221936. doi:10.1001/jamahealthforum.2022.1936
May 13, 2022
Viewpoint

Amplifying Appeals to the Common Good in COVID-19 Vaccine Messaging

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e220991. doi:10.1001/jamahealthforum.2022.0991

This Viewpoint highlights how appeals to self-interest as a means to encourage vaccination have come to prevail in the pandemic, and suggests a transition from this approach to appeals that reclaim a spirit of solidarity.

Original Investigation

Concordance of Hospital Ranks and Category Ratings Using the Current Technical Specification of US Hospital Star Ratings and Reasonable Alternative Specifications

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221006. doi:10.1001/jamahealthforum.2022.1006

This cross-sectional study aims to identify the changes in hospital ratings and rankings associated with alternative methodological choices in the calculation of the 2021 Centers for Medicare & Medicaid Services Hospital Compare star ratings.

COVID-19 and Hospital Financial Viability in the US

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221018. doi:10.1001/jamahealthforum.2022.1018

This cross-sectional study examines changes in the operational financial performance and overall financial viability of US hospitals during the COVID-19 pandemic.

Research Letter

Trends in Real Estate Investment Trust Ownership of US Health Care Properties

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221012. doi:10.1001/jamahealthforum.2022.1012

This cross-sectional study examines the prevalence and characteristics of real estate investment trust–owned health care properties in the US health care sector.

May 12, 2022
JAMA Forum

The Costs of Long COVID

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221809. doi:10.1001/jamahealthforum.2022.1809
May 10, 2022
In the News

Federal Investigators Find Medicare Advantage Plans Too Often Deny, Delay Needed Care

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221781. doi:10.1001/jamahealthforum.2022.1781
May 6, 2022
Viewpoint

Harnessing COVID-19 Data Through Collaboration—The Consortium of HCA Healthcare and Academia for Research Generation

Abstract Full Text
open access has audio
JAMA Health Forum. 2022;3(5):e220874. doi:10.1001/jamahealthforum.2022.0874

This Viewpoint describes the framework of a large COVID-19 research consortium that includes private, public-sector, and academic collaborating institutions.

Original Investigation

Evaluation of Federal Policy Changes to the Hospice Benefit and Use of Hospice for Persons With ADRD

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e220900. doi:10.1001/jamahealthforum.2022.0900

This cross-sectional study examines the association of hospice use among patients with Alzheimer disease and related dementias with the passage of the US IMPACT Act and implementation of the 2-tier payment system.

Research Letter

Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e220888. doi:10.1001/jamahealthforum.2022.0888

This economic evaluation examines the magnitude and trend of prescription drug rebates in commercial markets from 2015 to 2019 and identifies insurance plan factors associated with rebates.

JAMA Health Forum Masthead

JAMA Health Forum

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e220713. doi:10.1001/jamahealthforum.2022.0713
May 5, 2022
JAMA Forum

The Future of Medicare Advantage

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221684. doi:10.1001/jamahealthforum.2022.1684
May 3, 2022
In the News

FDA Outlines Proposed Ban on Menthol Cigarettes, Flavored Cigars

Abstract Full Text
open access
JAMA Health Forum. 2022;3(5):e221664. doi:10.1001/jamahealthforum.2022.1664
×